Characteristics and Disease Management in a Large Real World Lupus Nephritis Cohort in the U.S.
View our poster on Characteristics and Disease Management in a Large Real World Lupus Nephritis Cohort in the U.S. Click to view more!
View our poster on Characteristics and Disease Management in a Large Real World Lupus Nephritis Cohort in the U.S. Click to view more!
New Project Puts Standardized Outcomes Measures for Depression into Real-World Use, from Registries to the Clinic OM1 partners with AHRQ, ABFM, APA and others to implement BOSTON, July 17, 2019 —OM1, a leading health outcomes and technology company, today announced it is has been awarded the CAPSTONE – Outcome Measure Harmonization and Data Infrastructure for[…]
Read the decision memo: https://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=292
November 15, 2018 —OM1, a leading health outcomes and technology company, today announced the publication of new harmonized outcome measures for atrial fibrillation (AF) in HeartRhythm. OM1’s Richard Gliklich and Michelle Leavy collaborated on the development of the measures and co-authored the publication. The work was funded by the Agency for Healthcare Research and Quality (AHRQ) through[…]
On June 22-23, we were at the annual Becker’s Spine, Ortho and Pain conference in Chicago and talking about how we’re demonstrating that measured, precise and pre-emptive care generates real ROI. Interested in learning more or furthering our discussions? Contact us at info@om1.com.